NCT00619840View on ClinicalTrials.gov

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2006

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

methylphenidate hydrochloride

sustained release, 10 mg capsule 1-3 capsules twice daily according to an individual titration schedule

DRUG

Placebo

10 mg capsule 1-3 capsules twice daily according to an individual titration schedule

Trial Locations (1)

66421

Institute of Forensic Psychology and Psychiatry, Homburg/Saar

All Listed Sponsors
lead

Medice Arzneimittel Pütter GmbH & Co KG

INDUSTRY

NCT00619840 - Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD | Biotech Hunter | Biotech Hunter